Preventive radiotherapy of prostate cancer increases the chance of a definitive recovery

29 Sep, 2021

This article is only available in Dutch: original article.

Elective nodal radiotherapy in prostate cancer

10 Aug, 2021

In patients with prostate cancer who have a high risk of pelvic nodal disease, the use of elective whole pelvis radiotherapy is still controversial. Two large, randomised, controlled trials (RTOG 9413 and GETUG-01) did not show a benefit of elective whole pelvis radiotherapy over prostate-only radiotherapy. In 2020, the POP-RT trial established the role of elective whole pelvis radiotherapy in patients who have more than a 35% risk of lymph node invasion (known as the Roach formula). POP-RT stressed the importance of patient selection. In patients with cN1 (clinically node positive) disease or...

In 2020, 4,000 fewer cancer diagnoses were made in Belgium than expected, but the catching-up is hopeful

05 Jul, 2021

This article is only available in Dutch and French.

Association of survival and local radiotherapy to the bladder versus chemotherapy alone for patients with metastatic urothelial carcinoma (mUC)

15 Feb, 2021


Limited data exists on the role of local therapy for metastatic urothelial carcinoma of the bladder (mUC). Large database analysis have inherent limitations but can shed light on survival outcomes in a real-world population and in scenarios not easily studied in a randomized fashion. We hypothesized that in the NCDB, radiotherapy (RT) to the bladder plus chemotherapy (CT) would be associated with improved overall survival (OS) vs CT alone.


We queried the NCDB for newly diagnosed mUC cases (cT1-4 N0-3 M1) from 2004-2015 treated with CT alone vs CT plus RT to ≥ 45 Gy to the bl...

40 percent fewer cancer diagnoses in 2020

10 Feb, 2021

This article is only available in Dutch: original article

“Increased risk of excess mortality in cancer patients due to fear of corona contamination”

04 Feb, 2021

This article is only available in Dutch: original press release


26 Sep, 2019

Authors (in alphabetical order):

Alex De Caluwé, Institut Jules Bordet Katrien Erven, Iridium Kankernetwerk Carine Kirkove, Cliniques Universitaires Saint-Luc Vincent Remouchamps, CHU UCL Namur Liv Veldeman, UZ Gent Caroline Weltens, UZ Leuven


Curative treatment for breast cancer consists of surgery, radiotherapy and systemic treatments such as chemotherapy, antihormonal therapy and targeted agents. The local treatment options are breast conserving treatment, consisting of breast sparing surgery followed by radiotherapy, and mastectomy with or without radio...


26 Sep, 2019

Breast cancer is a disease that affects about 1 in 9 women in Belgium before the age of 75, but it is nowadays a highly curable disease for a majority of people. Radiotherapy plays an essential role in the treatment of breast cancer. When the breast is preserved during surgery, the addition of radiotherapy leads to a clear reduction in the risk of local relapse, i.e. relapse in the treated breast or the draining lymph nodes. For every 4 local relapses prevented, 1 breast cancer death can be prevented. This survival benefit is also seen after mastectomy, but only in lymph node positive patients...

Belgium plays a pioneering role in radiotherapy

23 Sep, 2019

Full article is available in Dutch.

The world of Radiation Therapy requests more attention and proper financing from the government in the battle against cancer.

02 Sep, 2019

Article available in Dutch and French.